Dr. Jeffrey Kaplan, MD

Dr. Kaplan practices at Good Samaritan Hospital in San Jose, California, part of HCA Healthcare.

Dr. Kaplan's NPI, 1083796379, was assigned on October 19, 2006. Dr. Kaplan graduated from Rutgers New Jersey Medical School in 1984. Dr. Kaplan holds California license G065628.

Dr. Kaplan's primary practice is Good Samaritan Hospital, at 2425 Samaritan Drive, San Jose, CA 95124 in Santa Clara County. The practice phone is (408) 559-2011.

Dr. Kaplan's primary practice is Good Samaritan Hospital in San Jose, California, part of HCA Healthcare. Dr. Kaplan is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Kaplan to 1 more hospital, named with a free account. Dr. Kaplan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Kaplan is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Kaplan's licenses on file in 3 states: California, Hawaii and Vermont.

Dmand AI lists amputation, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization, lymphedema and peripheral vascular disease among the conditions Dr. Kaplan treats.

CMS data shows 2,729 Medicare services from Dr. Kaplan across 27 procedure codes in 2024, for 1,041 Medicare patients. Medicare paid $211,731 for them.

CMS counts 1,041 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 75 to 84, with 436 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 74, with 54% women.

In 2024, Dr. Kaplan wrote 168 Medicare Part D claims for 65 patients. 92% of them were for generic drugs. CMS names the drug for 95 of them, across 5 drugs with 11 or more claims each, at $879 in total drug cost. In 2023, CMS named 83 claims across 4 drugs.

Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 595 procedures of removal of tissue by Dr. Kaplan, more than 97% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 62 general payments to Dr. Kaplan from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. MIMEDX Group, Inc. paid the most, $563.

Dmand AI lists 2 awards for Dr. Kaplan, most recently CMS Stage 1 2012 in 2011.

Dr. Kaplan graduated from Rutgers New Jersey Medical School in 1984. Dr. Kaplan is a member of ACS.

Dr. Kaplan is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.